{"SPADE_UN_28112": {"Sequence Information": {"Peptide Name": "Cathelicidin-4/Indolicidin [P3A][P7A][P10A], CP10A", "Sequence": "ILAWKWAWWAWRR", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "1HR1", "UniProt Entry": [{"uniprotId": "P33046", "uniprotUrl": "http://www.uniprot.org/uniprot/P33046", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria", "Pubmed ID": "10898680", "Reference": "Antimicrob Agents Chemother. 2000;44:2086-2092", "Author": "Friedrich CL, Moyles D, Beveridge TJ, Hancock RE", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/10898680"}, {"Title": "Interaction of cationic antimicrobial peptides with model membranes", "Pubmed ID": "11473117", "Reference": "J Biol Chem. 2001;276:35714-35722", "Author": "Zhang L, Rozek A, Hancock RE", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11473117"}, {"Title": "Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin.", "Pubmed ID": "8849687", "Reference": "FEBS Lett. 1996;395:48-52", "Author": "Subbalakshmi C, Krishnakumari V, Nagaraj R, Sitaram N", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/8849687"}, {"Title": "Probing the role of Proline in the antimicrobial activity and lipopolysaccharide binding of indolicidin.", "Pubmed ID": "25935286", "Reference": "J Colloid Interface Sci. 2015;452:148-159", "Author": "Bera S, Ghosh A, Sharma S, Debnath T, Giri B, Bhunia A", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25935286"}, {"Title": "Enhanced Synergism and Mechanism of Action Studies of Synthetic Antimicrobial Metallopeptides", "Pubmed ID": "33825350", "Reference": "ChemMedChem. 2021;16:2112-2120", "Author": "Thompson Z, Greve JM, Cowan JA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33825350"}], "Mass": 1829.16, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": -0.28, "Frequent Amino Acids": "WAR", "Absent Amino Acids": "CDEFGHMNOPQSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 8, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28112", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18549", "Similarity": 1.0, "Sequence": "ILAWKWAWWAWR"}, {"SPADE_ID": "SPADE_UN_25161", "Similarity": 1.0, "Sequence": "GILAWKWAWWAWRR"}, {"SPADE_ID": "SPADE_UN_28112", "Similarity": 1.0, "Sequence": "ILAWKWAWWAWRR"}], "Hemolytic Activity": "Human dermal fibroblasts:IC50=77.8±12.9 µM", "Target Organism": "Staphylococcus aureus ATCC 25923(MIC=4µg/ml),Staphylococcus aureus SAP 0017(MIC=4µg/ml),Staphylococcus haemolyticus(MIC=2µg/ml),Staphylococcus haemolyticus(MIC=1µg/ml),Staphylococcus epidermidis(MIC=2µg/ml),Enterococcus faecalis ATCC 29212(MIC=8µg/ml),Listeria monocytogenes NCTC 7973(MIC=1µg/ml),Streptococcus pyogenes ATCC 19615(MIC=1µg/ml),Corynebacterium xerosis(MIC=1µg/ml),Escherichia coli(MIC=8µg/ml),Escherichia coli W160-37(MIC=20-25µg/ml),Staphylococcus aureus ATCC 8530(MIC=2-4µg/ml),Saccharomyces cerevisiae PEP 4/3l(MIC=10-15µg/ml),Candida utilis CBS4511(MIC=10-15µg/ml),Escherichia coli DH5alpha(MIC=45µM),Salmonella typhimurium(MIC=50µM),Klebsiella pneumoniae(MIC=50µM),Pseudomonas aeruginosa(MIC=>100µM),Escherichia coli ATCC 25922(MIC=14.7±1.3µM),Staphylococcus aureus ATCC 43300(MIC=14.7±3.8µM),Acinetobacter baumannii(MIC=5.6±1.0µM),Enterococcus faecalis(MIC=2.0±0.0µM)"}}}